Skip to main content
. 2025 Jun 1;312(3):823–832. doi: 10.1007/s00404-025-08076-6

Table 1.

Characteristics of women in the study population

Variables Non-preeclampsia Preeclampsia P value
N = 1955 N = 108
Maternal age 32 (27, 34) 33 (27, 36.8) 0.063
Height (cm) 160 (163, 166) 162 (160, 165) 0.246
Admission weight (kg) 75 (68.5, 83) 84.5 (74, 97)  < 0.001
Maternal weight gain (kg) 15 (11, 19) 14 (10, 19.8) 0.315
Pre-pregnancy weight (kg) 60 (54, 67.5) 71 (59.5, 81)  < 0.001
BMI 22.58 (20.37, 25.16) 27.00 (22.84, 31.20)  < 0.001
SBP (mmHg) 121 (120, 122) 122 (120, 130)  < 0.001
DBP (mmHg) 70 (66, 75) 75 (68, 84.7)  < 0.001
MAP 86.67 (86.47, 93.33) 92.67 (85.33, 98.00)  < 0.001
GA at screening PlGF (wk. + d) 20.0 (16.1, 26.1) 22.2 (16.2, 27.3) 0.404
PlGF (pg./mL) 103 (74.2, 157) 76.5 (52.5, 112)  < 0.001
sFlt-1 (pg./mL) 1464 (1240, 1750) 1602 (1278, 1847) 0.048
sFlt-1/PlGF ratio 14.1 (9.38, 20.0) 22.8 (13.0, 33.0)  < 0.001
Nulliparity (Yes) 733 (37.5) 47 (43.5) 0.209
Type 1 or type 2 diabetes (Yes) 367 (18.8) 35 (32.4)  < 0.001
Pregnancy with hypothyroidism (Yes) 119 (6.09) 8 (7.41) 0.578
Pregnancy with hyperthyroidism (Yes) 5 (0.26) 0 (0.00) 1.000
History of adverse pregnancy (Yes) 102 (5.22) 19 (17.6)  < 0.001
Multifetal gestation (Yes) 71 (3.63) 6 (5.56) 0.305
Conception by ART (Yes) 143 (7.31) 9 (8.33) 0.693
Family history of PE (Yes) 6 (0.31) 9 (8.33)  < 0.001
History of PE (Yes) 4 (0.20) 8 (7.41)  < 0.001
Renal disease (Yes) 2 (0.10) 7 (6.48)  < 0.001
Chronic hypertension (Yes) 21 (1.07) 21 (19.4)  < 0.001
Autoimmune disease (Yes) 21 (1.07) 17 (15.7)  < 0.001
PPWPA (Yes) 2 (0.10) 0 (0.00) 1.000
Prior pregnancy with FGR (Yes) 2 (0.10) 0 (0.00) 1.000
Aspirin (Yes) 28 (1.43) 15 (13.9)  < 0.001
Previous history of stillbirth (Yes) 15 (0.77) 1 (0.93) 0.578
PCOS (Yes) 26 (1.33) 14 (13.0)  < 0.001

BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial pressure, GA gestational age, PlGF placental growth factor, sFlt-1 soluble fms-like tyrosine kinase-1, ART assisted reproductive technique, FGR fetal growth restriction, PCOS polycystic ovary syndrome, PPWPA prior pregnancy with placental abruption